This site is intended for healthcare professionals
Drug news

AMG 416 (etelcalcetide) non-inferior to oral cinacalcet in treatment of secondary hyperparathyroidism- Amgen

Read time: 1 mins
Last updated:9th Nov 2015
Published:9th Nov 2015
Source: Pharmawand
Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest